Worldwide Yearly Screening for Hypospadias
Launched by UNIVERSITY OF WISCONSIN, MADISON · May 2, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Worldwide Yearly Screening for Hypospadias (WYSH) trial is looking to understand how well a new online tool, called the Care Planning Tool, works for boys and men who have had surgery for a condition called hypospadias. Hypospadias is a condition where the opening of the urethra is not located at the tip of the penis. This study aims to find out if this tool is useful and accepted by about 20 male participants who have a history of this condition.
To participate, individuals must be males aged between 5 and 65 who have had surgery for hypospadias. Participants will be grouped by age, and parental consent will be needed for younger boys. Although the study is not yet recruiting participants, those who take part can expect to provide feedback on their experience using the Care Planning Tool, which may help improve care for future patients with hypospadias. This is an important step in ensuring that healthcare tools meet the needs of patients and their families.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males who have a documented history of repaired hypospadias.
- * Age groups targeted, based on recommended standards for user experience data from pilot studies:
- • 3-5 Males, age 5-10 (with parental consent and child assent)
- • 3-5 Males, age 11-15 (with parental consent and child assent)
- • 3-5 Males, age 16-20 (with parent consent, child assent until age 18)
- • 3-5 Males, age 21-65
- Exclusion Criteria:
- • -
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Vinaya Bhatia, MD
Principal Investigator
UW School of Medicine and Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported